128 related articles for article (PubMed ID: 2334843)
1. Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats.
Freo U; Soncrant TT; Ricchieri GL; Wozniak KM; Larson DM; Rapoport SI
Brain Res; 1990 Mar; 511(2):209-16. PubMed ID: 2334843
[TBL] [Abstract][Full Text] [Related]
2. Cerebral metabolic responses to meta-chlorophenylpiperazine are reduced during its chronic administration to young and aged rats.
Freo U; Larson DM; Soncrant TT
Gerontology; 1993; 39(6):305-13. PubMed ID: 8144044
[TBL] [Abstract][Full Text] [Related]
3. Age-related alterations in behavioral and cerebral metabolic responses to the serotonin agonist meta-chlorophenylpiperazine in rats.
Freo U; Rapoport SI; Soncrant TT
Neurobiol Aging; 1991; 12(2):137-44. PubMed ID: 2052128
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.
Freo U; Holloway HW; Greig NH; Soncrant TT
Psychopharmacology (Berl); 1992; 107(1):30-8. PubMed ID: 1534179
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats.
Freo U; Pietrini P; Pizzolato G; Furey-Kurkjian M; Merico A; Ruggero S; Dam M; Battistin L
Brain Res; 1995 Apr; 677(2):213-20. PubMed ID: 7552245
[TBL] [Abstract][Full Text] [Related]
6. Parachloroamphetamine selectively alters regional cerebral metabolic responses to the serotonergic agonist metachlorophenylpiperazine in rats.
Freo U; Larson DM; Tolliver T; Rapoport SI; Soncrant TT
Brain Res; 1991 Mar; 544(1):17-25. PubMed ID: 1713115
[TBL] [Abstract][Full Text] [Related]
7. Dose- and time-dependent effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats.
Freo U; Soncrant TT; Holloway HW; Rapoport SI
Brain Res; 1991 Feb; 541(1):63-9. PubMed ID: 2029625
[TBL] [Abstract][Full Text] [Related]
8. The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats.
Freo U; Pietrini P; Dam M; Pizzolato G; Battistin L
Psychopharmacology (Berl); 1993; 113(1):53-9. PubMed ID: 7862829
[TBL] [Abstract][Full Text] [Related]
9. Cerebral metabolic effects of serotonin drugs and neurotoxins.
Freo U
Life Sci; 1996; 59(11):877-91. PubMed ID: 8795699
[TBL] [Abstract][Full Text] [Related]
10. Time- and dose-dependent effects of corticotropin releasing factor on cerebral glucose metabolism in rats.
Freo U; Ori C; Weiss SR; Perini GI
J Neural Transm (Vienna); 2005 Nov; 112(11):1447-62. PubMed ID: 15843869
[TBL] [Abstract][Full Text] [Related]
11. Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP.
Sills MA; Lucki I; Frazer A
Life Sci; 1985 Jul; 36(26):2463-9. PubMed ID: 4010463
[TBL] [Abstract][Full Text] [Related]
12. The time-dependent effects of midazolam on regional cerebral glucose metabolism in rats.
Freo U; Dam M; Ori C
Anesth Analg; 2008 May; 106(5):1516-23, table of contents. PubMed ID: 18420870
[TBL] [Abstract][Full Text] [Related]
13. Cerebral metabolic responses to clomipramine are greatly reduced following pretreatment with the specific serotonin neurotoxin para-chloroamphetamine (PCA). A 2-deoxyglucose study in rats.
Freo U; Pietrini P; Pizzolato G; Furey M; Merico A; Ruggero S; Dam M; Battistin L
Neuropsychopharmacology; 1995 Nov; 13(3):215-22. PubMed ID: 8602894
[TBL] [Abstract][Full Text] [Related]
14. Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats.
Freo U; Ricchieri GL; Holloway HW; Soncrant TT
Brain Res; 1993 Jan; 600(2):249-56. PubMed ID: 8435750
[TBL] [Abstract][Full Text] [Related]
15. Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR.
Cohen ML; Kurz KD; Fuller RW
Clin Exp Hypertens A; 1987; 9(10):1549-65. PubMed ID: 3677442
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys.
Aloi JA; Insel TR; Mueller EA; Murphy DL
Life Sci; 1984 Apr; 34(14):1325-31. PubMed ID: 6708733
[TBL] [Abstract][Full Text] [Related]
17. Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion.
Ulrichsen J; Partilla JS; Dax EM
Psychopharmacology (Berl); 1992; 107(2-3):229-35. PubMed ID: 1352053
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.
Jones N; Duxon MS; King SM
Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085
[TBL] [Abstract][Full Text] [Related]
19. Effects of anesthesia and recovery from ketamine racemate and enantiomers on regional cerebral glucose metabolism in rats.
Freo U; Ori C
Anesthesiology; 2004 May; 100(5):1172-8. PubMed ID: 15114215
[TBL] [Abstract][Full Text] [Related]
20. Sensitization to 5-HT1C receptor agonist in rats observed following withdrawal from chronic ethanol.
Rezazadeh SM; Prather PL; Lal H
Alcohol; 1993; 10(4):281-3. PubMed ID: 8397879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
